Dr. Samir Dalia, MD
Claim this profileMercy Research Joplin
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
13 drugs studied
Area of expertise
1Lung Cancer
Stage IV
BRAF negative
ROS1 negative
2Non-Small Cell Lung Cancer
Stage IV
BRAF negative
ROS1 negative
Affiliated Hospitals
Clinical Trials Samir Dalia, MD is currently running
Observation
for Non-Small Cell Lung Cancer
GEMINI NSCLC Study is a non-interventional study that will be collecting clinical and molecular health information from patients with NSCLC who will receive longitudinal blood collection in addition to their standard of care therapy and disease surveillance with the goals of identifying the molecular evolution of lung cancer with standard of care therapy, and determining the utility of ctDNA dynamics to predict risk of recurrence and therapeutic outcomes.
Recruiting1 award N/A10 criteria
Biomarker Profiling
for Colorectal Cancer
The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.
Recruiting1 award N/A5 criteria
More about Samir Dalia, MD
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Samir Dalia, MD has experience with
- Pembrolizumab
- N-803
- Pemetrexed
- Carboplatin
- Nab-paclitaxel
- Avelumab
Breakdown of trials Samir Dalia, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Samir Dalia, MD specialize in?
Samir Dalia, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are BRAF negative.
Is Samir Dalia, MD currently recruiting for clinical trials?
Yes, Samir Dalia, MD is currently recruiting for 3 clinical trials in Joplin Missouri. If you're interested in participating, you should apply.
Are there any treatments that Samir Dalia, MD has studied deeply?
Yes, Samir Dalia, MD has studied treatments such as Pembrolizumab, N-803, Pemetrexed.
What is the best way to schedule an appointment with Samir Dalia, MD?
Apply for one of the trials that Samir Dalia, MD is conducting.
What is the office address of Samir Dalia, MD?
The office of Samir Dalia, MD is located at: Mercy Research Joplin, Joplin, Missouri 64804 United States. This is the address for their practice at the Mercy Research Joplin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.